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Studies of the human IgE antibody response have been limited by the lack of 
reproducible in vitro models for the induction of IgE synthesis by B cells from 
normal individuals (1-7). Polyclonal B cell activators, such as PWM or EBV have 
failed to induce IgE synthesis in peripheral blood B cells of both nonatopic and 
allergic donors (4,  6-7). Several laboratories, however, have found that culture 
supernatants of unfractionated T  cells from patients with extremely high serum 
IgE levels e.g. hyper-lgE syndromre (HIE) 1 induce significant IgE synthesis by 
normal B cells, whereas supernatants from the T  cells of normal subjects do not 
induce IgE synthesis by normal B cells (4, 8, 9).  These results suggested that T 
cells from HIE patients but not normal donors secreted helper factors that were 
required for the induction of IgE synthesis, 
Recently (10),  we have established Fc~R  + and Fc~R- T  cell lines from patients 
with HIE. Supernatants from the Fc~R  + T  cell lines secreted IgE binding factors 
that specifically potentiated IgE production by B cells from patients with peren- 
nial allergic rhinitis but not B cells from normal nonatopic donors (10).  These 
observations suggest the need for additional T  cell-derived signals that bring 
normal B cells to a level of activation that is responsive to IgE binding factors. 
Several laboratories, including our own, have shown that human alloreactive 
helper T  cell clones could activate B cells from normal donors to produce high 
levels of IgM, IgG, IgA, and IgE (1 1-13). In this study, we report an alloreactive 
helper T  cell clone that was capable of inducing normal B cells to synthesize 
IgG, but not IgE. However, addition of T  cell-derived IgE potentiating factors 
to normal B cells preactivated with this alloreactive helper T  cell clone resulted 
in the induction of IgE synthesis. These experiments further define the sequential 
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requirements  for differentiation  of normal  B  cells  into  IgE-secreting plasma B 
cells. 
Materials and  Methods 
Isolation  of Mononuclear  Cell  Subpopulations.  Peripheral  blood  mononuclear  cells 
(PBMC)  were  isolated  from  heparinized  peripheral  blood  by  Ficoll-Hypaque  density 
gradient  centrifugation.  The  isolated  PBMC  were  washed  three  times  in  HBSS  and 
suspended in  RPMI  1640  medium containing  10%  AB  + serum. Suspensions of PBMC 
were depleted of adherent ceils by allowing them to incubate for  I  h at 37°C in plastic 
petri dishes  (5  ×  10  6  cells/ml).  Cell  suspensions enriched  in  B  cells were prepared by 
rosetting  nonadherent  mononuclear cells  with  sheep erythrocytes (E)  pretreated  with 
neuraminidase, and recovering the non-rosette forming cells by centrifugation over Ficoll- 
Hypaque as previously described (14).  After repeating the rosetting procedure a second 
time, the non-rosette forming cells were collected. They contained 70-85% surface Ig- 
positive cells, and <2% E  + cells. 
Preparation of Monocytes.  PBMC were incubated overnight in petri dishes at 37°C in 
media  containing  10%  AB  +  serum.  Nonadherent  cells  were  then  removed  and  the 
remaining adherent cells were washed with warm media. Ice cold PBS was added to the 
dishes, and the monocytes were aspirated and resuspended in  RPMI  1640.  Monocytes 
were irradiated (2,500 rad) before being added to 96-well plates (2 ×  104 ceUs/weU). 
Preparation of T  Cell Clones.  Alloreactive T  cell clones were obtained as previously 
described (11,  t 5).  107 PBMC from a nonatopic HLA-DR3,4 donor were stimulated with 
107 irradiated (5,000 rad) PBMC from a nonatopic HLA-DR5,6 donor in 10 ml of RPMI 
1640  (M.  A.  Bioproducts,  Walkersville, MD) containing penicillin  (I00  U/ml), strepto- 
mycin (50 ~g/ml), and 10% heat-inactivated FCS (complete medium). After incubation at 
37°C in 5% CO~ for 6 d, the cultures were harvested, and dividing cells were enriched 
by centrifugation over a  Perco]l (Pharmacia Fine Chemicals, Upsala, Sweden) discontin- 
uous (30, 50, 70, 90%) gradient at 1,500 g for 45 min. Cells at the 30]50% interface were 
resuspended in complete medium supplemented with 25%  IL-2-containing supernatants 
(IL-2-Sup) that  contained  irradiated  (5,000  rad)  allogeneic  PBMC.  The  mixture  was 
distributed  in  the  wells  of 96-well  trays (Nunc,  Roskilde,  Denmark).  Each  0.2-#1  well 
contained an average of 0.3  T  cell blast and  105 irradiated allogeneic PBMC.  Cultures 
were fed twice weekly: once with IL-2 Sup (25% vol/vol), and once with IL-2 Sup (25% 
vol/vol) and irradiated allogeneic PBMC (105 cells). After 14-21 d of culture, the contents 
of wells  exhibiting  cell  growth  were transferred to  the  wells  of 24-well  trays (Linbro 
Scientific Co., Hamden, CT) and expanded with IL-2 Sup in the presence of stimulator 
cells until a sufficient cell number was available for experiments. The clones so obtained 
were tested for their capacity to proliferate in response to the original stimulator in the 
absence of exogenous growth factors. 
IL-2 Sup.  PBMC  were obtained from normal donors previously screened  for their 
capacity to generate high-activity IL-2. PBMC were depleted of monocytes by adherence 
to plastic petri dishes and the nonadherent cells were irradiated  with  1,000  rads.  Cells 
were suspended at  106 cells/ml in RPMI  1640 with 2% FCS containing PHA (1  t~g]ml, 
Wellcome Labs., Research Triangle Park, NC), and supernatants were harvested after 48 
h. 
Proliferation  Assays.  4 ×  104 cloned T  cells were added to triplicate cultures in 96-well 
flat-bottom microtiter  plates  to  irradiated  (2,500  tad)  adherent  monocytes (2  ×  104 
cells/well). Thymidine incorporation was assessed by pulsing with 0.8  ~Ci methyl-[~H]- 
thymidine (New England Nuclear, Boston, MA) during the last 18 h of a 96-h culture. 
Establishment  of T  Cell Lines  with Receptors for Human IgE (Fc,R).  The isolation and 
establishment of Fc~R  + T  lymphocyte lines from patients with HIE has been described in 
detail  elsewhere (10).  Briefly, E-rosetted T  lymphocytes from patients with  HIE were 
incubated with I 0 gg/ml of human myeloma IgE P.S. (kindly provided by Dr. K. Ishizaka, 
Johns Hopkins University, Baltimore, MD). After a  1-h incubation at 4°C, the cells were 
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After a 45-min incubation at 4°C, the ce]Is were washed twice,  analyzed, and sorted for 
Fc,R  + and Fc,R- cells on the FACS IV cell sorter. Background staining was assessed with 
a control group of cells incubated with  10 ug/ml of human myeloma IgG instead of IgE. 
The FqR  + and Fc~R- T  cell fractions obtained from the FACS IV were suspended in 
growth medium and seeded into the wells of a microtiter plate at 0.5 x  l0 6 cells/ml, 0.2 
ml/well.  The growth medium consisted of RPMI 1640 and ITS medium (Collaborative 
Research  Inc.,  Lexington,  MA)  supplemented  with  10%  heat-inactivated  FCS,  with 
penicillin  (100 U/ml), streptomycin (50/ag/ml), L-glutamine (2 raM), and with  20%  IL-2 
Sup.  RPMI  1640/ITS medium  contained  5  •g/ml  insulin,  5 /~g/ml  transferrin,  and  5 
ng/ml selenium. 
2-3 wk after initiation of the culture, cells growing in microtiter wells were transferred 
to 24-well Linbro plates (Linbro Inc., New Haven, CT). Feeder cells (0.5-1.0 X 106/well) 
consisted of autologous PBL irradiated with 2,500 rad. T  cells in 24-well plates were fed 
every 3-4 d with IL-2, and every 1-2 wk with IL-2 and feeder cells. Immunofluorescence 
studies on Fc~R  + T  cell lines have revealed a surface phenotype consisting predominantly 
of Fc,R  +, T3 +, T4  +, Ia  + T  cells with <2% M 1  + cells, and no detectable B 1  + cells (10). 
Preparation oflgE Potentiating Factor(s) (IgE-PF).  Supernatants from Fc,  R + and Fc,  R- 
T cell lines were collected and passed through Centrifio CF50A cones (Miltipore,  Bedford, 
MA) to remove any IgE carried over from the initial  incubation with  10/~g/ml of IgE 
done before separation of Fc~R  + cells from Fc,  R- cells or from IgE released by irradiated 
autologous feeder  cells. The  IgE-free  filtrates  were  then  passed  through  a  0.45-t~m 
M illipore filter and stored at -20 °C until tested for their capacity to enhance IgE synthesis. 
In previous studies (10),  we showed that supernatants from Fc,  R + T  cell lines but not 
from Fc~R- T  cell lines contained IgE binding factors (IgE-BF) that selectively  enhanced 
IgE synthesis  in  cultures of B cells obtained from patients with allergic rhinitis  but not 
from normal  nonatopic subjects (10).  Purified  IgE-BF from Fc,R  + T  cell  supernatants 
were isolated by absorption with IgE immobilized on Sepharose and recovery of IgE-BF 
in the acid eluates from these beads, as previously described (10). 
Ig Synthesis in Cell Cultures.  Cells were suspended in RPMI 1640 medium containing 
10% FCS and grown in 96-well microtiter plates in a humidified atmosphere of 5% CO2 
at  37°C.  Each microtiter  well contained:  10 ~ cell-enriched E-cells,  2  x  104 irradiated 
(2,500  rad)  monocytes (to  activate  the  T  cell  clones)  and,  when  indicated,  4  x  104 
irradiated  (2,500 rad) cloned T  cells.  After 4 d  of culture, the cells were washed twice 
with culture medium to remove IgE released during the first 4 d of culture. In previous 
studies (11) we showed that this uniformly reduced the amount of IgE associated with the 
cell pellet derived from nonatopic donors to <150 pg/ml. Fresh medium was added and 
cultures were incubated for an additional 8 d. Supernatants were harvested from triplicate 
cultures and assayed for IgE and  IgG content.  IgE associated with  the  cell  pellet  was 
determined by acid treatment of B cells on day 4 of culture, as described by Turner et al. 
(6). De novo or net IgE synthesis  was calculated by subtracting the values for IgE obtained 
in  day  4  acid-treated  cell  pellets,  i.e.,  preformed  IgE,  from  IgE  values  of day  12 
supernatants plus day 12 cell pellets. 
RIAfor IgE.  Duplicate samples from each culture were analyzed for their IgE content. 
The RIA for IgE was performed in flexible flat-bottom microtiter plates (Cooke Labora- 
tory Products, Alexandria, VA). The wells were filled with 0.1  ml of a  10 t~g/ml solution 
of a  1:1 mixture of two anti-human IgE Fc-specific mAb. These two antibodies (mAb 8 
and 9) were the kind gift of Dr. Siraganian, National Institutes of Health, Bethesda, MD. 
After incubation for 16 h, the coating solution was removed, and the wells were washed 
and blocked with  10% horse serum (HS) in PBS for 2 h. After washing three times with 
PBS containing 1% HS, 0.1  ml of culture supernatant or of IgE standard was added to 
each of the  triplicate  wells and  incubated  for  16 h  in  a  humidified chamber at  room 
temperature. The wells were then washed twice with PBS plus  1%  HS containing 0.5% 
Tween 20, and twice with  PBS plus  1%  HS, then 0.1  ml of Phadebas RAST ~25I-anti- 
human IgE (ND) (sp act,  12 ~Ci/~g; Pharmacia Fine Chemicals)  was added to each well. 
6  b  later,  the radiolabeled anti-IgE was removed.  Wells  were then  washed three times 
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out and counted in a  Gamma  spectrometer (Tracor Analytic, Elk Grove Village,  IL). 
Standard curves were constructed using dilutions of the  IgE standards obtained from 
Pharmacia Fine Chemicals. The concentration of IgE in the supernatants was read from 
the standard curve. The lower limit of sensitivity of this assay varied from 150-300 pg]ml. 
The specificity and sensitivity of our IgE RIA was confirmed in a recently completed 
multiinstitutional  study  coordinated  by  the  Mayo  Clinic  (Helm,  Buckley,  Adkinson, 
Squillace, Gleich, and Yungingen, manuscript submitted for publication). Coded samples 
with varying quantities of polyclonal IgE in the presence of other Ig isotypes sent to our 
laboratory were evaluated using our IgE RIA. In no test sample were falsely elevated IgE 
values measured in our laboratory, thus ruling out the possibility of crossreactivity with 
other isotypes. Furthermore, values of IgE >300 pg/ml were measured accurately with a 
mean deviation from the expected values of <20%. 
EL1SA of  Supernatants for lgG.  96-well polystyrene plates were coated with immunoab- 
sorbent-purified goat anti-IgG (Tago, Inc., Burlingame, CA) (10 #g]ml). After washing 
with PBS containing 0. 1% Tween 20, the plates were incubated with a solution of 0. 1% 
gelatin for 1 h. The plates were washed, and 0.1  ml of appropriately diluted supernatants 
were added  to the  wells.  After  18  h,  the plates  were again washed and horse radish 
peroxidase-conjugated anti-IgG (Tago, Inc.) was added (1:300). The plates were incu- 
bated for 1 h at 37°C, washed, and the bound antibody conjugate was quantitated using 
the substrate azino-diethyl-benzthiazoline sulfonic acid.  Plates were incubated with the 
substrate for 30 rain, and the absorbance at 414 nm was read on a Titertek Multiskan 
Spectrophotometer (Flow Laboratories, Inc., McLean, VA). Standard curves were per- 
formed  using  purified  Ig  (Kallestad,  Austen,  TX).  The specificity of the  conjugated 
antisera  was  ascertained  by  testing  them  in  a  direct  ELISA  against  purified human 
myeloma IgG, IgM, IgA, and ~ and ~ Bence-Jones proteins. 
Mouse mAb.  Antibodies  to  human  HLA-DR  and  to  human  HLA-A,B  framework 
antigens were obtained from Becton Dickinson Monoclonal Center (Mountain View, CA). 
Results 
Some AUoreactive T Cell Clones lnduce Synthesis of IgG But Not IgE.  After the 
initial  cloning of T  cell blasts  from a  nonatopic (serum  IgE,  20  IU/ml)  HLA- 
DR3,4 donor stimulated with irradiated PBMC from a  nonatopic HLA-DR5,6 
donor, we obtained two alloreactive T  cell clones: 2H6 and 3A3. Each of these 
clones was IL-2-dependent and gave a strong proliferative response to irradiated 
PBMC  from  the  original  stimulator,  but  not  to  irradiated  autologous  PBMC 
(Table  I).  Furthermore,  the  alloreactive  response  of these  T  cell  clones  to 
irradiated stimulator PBMC was blocked by mAb against HLA-DR antigen but 
not by anti-HLA-A,B (Table I). The surface phenotype of these clones was T3  ÷, 
T4  ÷, HLA-DR  +, and T8-. 
Clones 2H6 and 3A3 were examined for their capacity to induce IgG and IgE 
synthesis in B cells from the donor of the original stimulator PBMC.  As shown 
in Table II, the B  cells from this nonatopic donor made low levels of IgG but 
undetectable levels of IgE. Coculture of these B cells with the two T  cell clones 
resulted in high levels of IgG synthesis, but failed to stimulate detectable levels 
of IgE synthesis. 
Induction  of IgE  Synthesis by  Clone IIH6  Requires IgE-PF.  In  this  series  of 
experiments, we explored the possibility that IgE-PF(s) derived from HIE Fc,R  + 
T  cell lines were required for the successful  induction of IgE synthesis by the 
alloreactive helper T  cell clones as shown  in  Table II.  Thus,  B  cells from the 
clone stimulator were cultured with T  cell clones in the presence or absence of 
culture supernatants from the HIE Fc,R  + and Fc,R- T  cell lines, and the B cells 
were examined for their capacity to produce IgE. LEUNG  ET  AL.  717 
TABLE  I 
Specificity of Alloreactive T Cell Clones 




2H6  3A3 
Medium  --  2,755  444 
IL-2 Sup  --  81,369  48,428 
Autologous monocytes  --  4,010  795 
Stimulator monocytes  --  89,237  55,232 
Stimulator monocytes  Anti-HLA-A,B  100,870  54,244 
Stimulator monocytes  Anti-HLA-DR  9,050  831 
The capacity of IL-2, x-irradiated (2,500 rad) autologous and allogeneic 
(stimulator)  monocytes  to stimulate the proliferation of clones 2H6 or 
3A3 over a 4-d culture period was studied.  Cultures did not have IL-2 
unless specified. Proliferative response is expressed as cpm [~H]thymidine 
incorporated into cutures. Values represent the mean of triplicate cultures; 
all SD were <10%. Irradiated monocytes incorporated <300 cpm. 
TABLE  II 
Some Alloreactive T Cell Clones Do Not Induce IgE Synthesis 
Exp. 
Cells in culture  Ig produced 
B cells  T cell clone  IgG  lgE 
ng/ml  pg/ml 
+  2H6  4,655  <150 
+  3A3  3,270  <150 
+  --  155  <150 
+  2H6  5,140  <150 
+  3A3  4,935  <150 
+  --  127  <150 
+  2H6  4,220  <150 
+  3A3  3,870  <150 
+  --  95  <150 
All  cultures contained  10  ~ E-rosette-negative cells (B  ceils). Cultures 
stimulated with T  cell clones received  4 x  104 irradiated (2,500 rad) T 
cell clones. All cultures were washed on day 4, and supernatants from day 
4 to day  12 were collected and assayed for Ig content. Preformed IgE 
values on day 4 of culture were <150 pg IgE per milliliter. The results 
represent the mean Ig determinations  of triplicate cultures. SD were <10% 
of the mean. 
The results in Table III show that B  cells from this nonatopic donor failed to 
synthesize IgE in the presence of culture supernatants from either the Fc,  R + or 
Fc,R- T  cell lines. However, when the same B  cells were cocultured with clone 
2H6 in the presence of Fc,R  + T  cell supernatants containing IgE-PF, a high level 
of IgE synthesis was observed.  In contrast,  Fc,R- T  cell supernatants failed to 
activate  IgE  synthesis by  B  cells  cocultured  with  clone  2H6.  The  capacity of 
clone  2H6  to  induce IgE  synthesis in the  presence of IgE-PF appears  to  be a 
unique feature of this T  cell clone, because T  cell clone 3A3 (Table III), as well 718  INDUCTION OF  lgE  SYNTHESIS  IN  NORMAL  HUMAN  B  CELLS 
TABLE  III 
Induction of lgE Synthesis by Clone 11146 Requires Fc,R  + 
T Cell Supernatant 
Cells in culture  Supernatant  Ig Produced 
cells  T cell clones  added  IgG  IgE 
ng/ml  pg/ml 
+  --  Fc-R-  90  < 150 
+  --  Fc-R  +  95  <150 
+  llH6  Fc-R-  3,900  <150 
+  IIH6  Fc-R  +  4,100  2,500 
+  ILIA3  Fc-R-  4,650  <150 
+  ILIA3  Fc-R  ÷  4,900  <150 
Cultures contained l0  s E-rosette-negative cells (B cells), and where indi- 
cated, 4 ×  104 irradiated T cell clones and a I: 10 dilution of Fc-R- or Fc- 
R  ÷ T  cell supernatants.  All cultures were washed  on day 4, replenished 
with  fresh  medium containing  Fc~R  + or  Fc,R- T  cell supernatant,  and 
culture medium was collected from day 4 to day 12 for lg determination. 
Preformed IgE values on day 4 of cuhure were <150 pg IgE per milliliter. 
The results  represent the mean Ig determinations of triplicate  cultures. 
Similar results were obtained in two other experiments. 
TABLE  IV 
Induction of IgE SyntheSis by Clone IIH6 Requires 
lgE Binding Factor(s) 
Cells in culture  Ig produced 
Supernatant added 
B cells  Clone IIH6  IgG  IgE 
ng/ml  pg/ml 
+  -  Medium  80  <150 
+  +  Medium  5,200  <150 
+  +  Fc~R  +  5,350  3,520 
+  +  lgE-Sepharose  effluent  5,250  <150 
+  +  IgE-Sepharose  eluate  5,100  2,700 
+  +  IgE-Sepbarose  effluent  5,100  4,050 
+  +  IgG-Sepharose  eluate  5,300  <150 
Culture conditions  are similar to those described  in Table Ill. Preformed 
IgE values determined on day 4 of culture were <150 pg IgE per milliliter. 
as  three  other  alloreactive T  cell  clones  tested  directed  against  two  different 
donors  failed  to  induce  IgE  synthesis  in  B  cells  of  stimulator  origin  in  the 
presence of either Fc,R  + or Fc~R- T  cell supernatants  (results not shown). 
We next examined whether the IgE-potentiating activity of supernatants  from 
Fc~R  + T  cells was contained within the  IgE binding fraction. Supernatants  were 
passed  over  Sepharose  4B  conjugated  to  human  myeloma  IgE  or  to  human 
myeloma  IgG,  and  the  effluents and  eluates  from  these  columns were assayed 
for their capacity to enhance IgE synthesis when the B cells were cocultured with 
clone  2H6.  Table  IV  shows  that  the  effluent  from  the  IgE-Sepharose column LEUNG  ET AL. 
TABLE  V 
Sequential Requireraents  for Induction of lgE Synthesis by Clone IIH6 
and IgE Potentiating Factor (IgE-PF) 
Treatment of B cells on:  Ig synthesis 
Day 1  Day 4  IgG  IgE 
ng/ral  pg/ml 
--  --  120  <150 
IgE-PF  IgE-PF  150  <150 
Clone IIH6  Clone IIH6  4,500  <150 
Clone IlH6 + IgE-PF  Clone IIH6 + IgE-PF  4,700  4,750 
Clone IIH6  OKT3 lysis + IgE-PF  1,200  5,267 
IgE-PF  Clone IIH6  3,800  375 
Culture  conditions are similar to those described in Table  lII.  In  the 
experiment on line 5, B cells were initially cultured  for 4 d with clone 
IIH6. Subsequently the T cell clones were ]ysed with OKT3 mAb and 
complement. The remaining B cells were washed and IgE IgE-PF, i.e., 
Fc,R  ÷ T  cell supernatants  were  added  at  1:10 final dilution.  In  the 
experiment on line 6, B cells were treated with lgE-PF for 4 d, washed, 
and  4  x  l04  irradiated  (2,500  rad)  IIH6  cells were added.  Culture 
supernatants were collected from day 4 to day 12 for Ig determination. 
Preformed IgE was <150 pg/m] on day 4 of cultures. 
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lost its capacity to enhance IgE synthesis. In contrast, the effluent from the IgG- 
Sepharose  column  retained  its  full  capacity  to  enhance  IgE  synthesis.  More 
importantly, the material that bound to the IgE immunosorbent, and which was 
eluted with  0.2  M  glycine-HCl potentiated IgE synthesis,  whereas  the material 
eluted from the IgG immunosorbent did not. The enhancement of IgE synthesis 
by the material  that bound to the IgE column was isotype-specific, because this 
material did not enhance IgG synthesis. 
Activation  of IgE  Synthesis  Requires  Two  Sequential Signals.  We  studied  the 
sequence of events resulting in the activation of IgE synthesis by normal B cells 
cultured in the presence of clone 2H6 and  IgE-PF(s).  We cocuhured normal B 
cells  with  clone  2H6  for  4  d.  T  cells  were  then  lysed  with  OKT3  mAb  and 
complement,  and  the  remaining  B  cells were  incubated  for an  additional  8  d 
with IgE-PF. Table V shows that this resulted in a high level of IgE synthesis. In 
contrast, when B cells were initially cultured with IgE-PF, washed on day 4, and 
then cocuhured with clone 2H6 for an additional 8 d, only a minimal amount of 
IgE synthesis occurred (Table V). As expected, vigorous IgE synthesis occurred 
when B cells were cultured with both clone 2H6 and IgE potentiating factor for 
4  d, washed,  then recuhured in the presence of both stimuli (Table V). No IgE 
synthesis occurred in B cells cultured for the entire  12-d period in the presence 
of medium, clone 2H6, or IgE-PF alone with a control wash at day 4 (Table V). 
Discussion 
Herein, we identify two sequential  signals  required for the activation of IgE 
synthesis by normal B cells. The first signal is delivered by the alloreactive T  cell 
clone 2H6, and the second signal was delivered by IgE-BF(s) secreted by Fc-R  + 
T  cell lines from patients with HIE. This activation of IgE synthesis was isotype- 720  INDUCTION  OF  lgE  SYNTHESIS  1N  NORMAL  HUMAN  B  CELLS 
specific because no  changes were observed in  IgG  synthesis by the same cell 
cultures. 
Current models of B  cell differentiation suggest  that  B  cell differentiation 
factors (BCDF) act on target B cells previously activated by various ligands, such 
as Staphylococcus  aureus Cowan 1 strain or anti-lg (16,  17).  Since unfractionated 
T  cell supernatants from patients with HIE are capable of inducing IgE synthesis 
in normal B cells (4), but IgE-BFs from the same patients are incapable of doing 
so, we postulated that T  cell-derived factors are required to bring resting B cells 
to a  level of activation that is responsive to IgE-BF. The results obtained from 
this investigation are consistent with this hypothesis. Indeed, clone 2H6 induced 
normal B cells to respond to IgE-PF. Although the target of IgE-PFs are activated 
B cells, the results described herein do not exclude the possibility that BCDF is 
released from al]ogeneic T  cells, and IgE-PF is an additional factor. 
Extensive studies by Ishizaka and coworkers have shown that IgE-BFs secreted 
from murine T  lymphocytes bearing receptors for IgE (Fc,R  +) have an important 
role  in  the  isotype-specific regulation of IgE  synthesis (18).  Rat  IgE-binding 
factors consist of two activities:  IgE-PFs (19) and IgE-suppressive factors (20). 
lgE-PFs are secreted by T  cells from rats subjected to immunization regimens 
that are favorable for the formation of IgE antibodies, whereas IgE-suppressive 
factors are secreted by T  cells from rats immunized under conditions that favor 
IgG but not IgE responses. Both factors have tool wt ~ 15,000 but differ in their 
carbohydrate content. The  IgE-PF(s) had affinity for lentil lectin and Con A, 
whereas the IgE-suppressive factor does not bind to the lectins but has affinity 
for peanut agglutinin. The rat IgE-PF has been shown to mediate its action via 
antigen-activated IgE-bearing B cells (19). We have previously reported (10) that 
human IgE-PF also stimulates IgE synthesis via IgE-bearing B cells from patients 
with allergic rhinitis and recent allergen exposure. The data from our current 
investigation strongly suggest that human IgE-PF and rodent IgE-PF have similar 
cell targets i.e. preactivated IgE-bearing B cells. 
Recently, several laboratories,  including our own (I 1-13),  have shown that 
some alloreactive T  cell  clones  stimulated  B  cells  from  nonatopic donors  to 
synthesize IgE antibody. Such clones presumably provided the full spectrum of 
signals required for the activation of IgE synthesis by normal B cells. On the 
other hand, we show herein that there are also alloreactive T  cell clones (clone 
3A3 and three other clones studied) that can stimulate IgG synthesis, but which 
are unable to stimulate IgE synthesis even in the presence of IgE-PF. The basis 
for the differential capacity of alloreactive T  cell clones to induce IgE synthesis 
in normal B cells is currently not known. We postulate, however, that alloreactive 
T  cell clones may vary in their capacity to secrete certain lymphokines essential 
for the development of the IgE antibody response. Thus, clones such as 3A3, 
which do not stimulate IgE synthesis even in the presence of IgE-PF may not 
secrete optimal  amounts  of other  lymphokines (BCDF,  B  cell  growth  factor 
[BCGF], IFN-~,,  etc.) required for induction of IgE synthesis. This hypothesis is 
supported by the recent observation by Goldstein et al. (21) of a T4 +, Leu-8  + T 
cell clone that  secreted BCDF  but  could  support  IgG  production  only when 
exogenous BCGF was added to the cultures. 
The basis for the differential response of IgG and IgE synthesis to alloreactive LEUNG ET AL.  721 
T  cell clones may relate to the in vivo activation status of B cells committed, 
respectively, to IgG and IgE synthesis in normal subjects. The lack of spontaneous 
IgE synthesis by normal circulating B cells suggests that few if any IgE B cells 
circulate in an activated state in normal nonatopic subjects. In contrast, B cells 
from normal individuals spontaneously produce IgG. The majority of the in vivo 
activated B cells that spontaneously secrete IgG are large, and have been shown 
to reside in the less dense fractions of a density gradient, and to respond to T 
cell-dependent, PWM-triggered activation (22), and T  cell-derived factors (23). 
It is not known whether the T  cell clones activate B cells already committed 
to express IgE and/or are also causing isotype switching of B cells to synthesize 
Ig of the IgE isotype.  In this regard, there is evidence that T  cell clones can 
cause B cells to undergo isotype switch. Mayer et al. (24) have reported on the 
capacity of monoclonal human leukemic T  ceils to cause an IgM to IgG switch 
in B cells of patients with the hyper-IgM syndrome. More recently, Strober and 
coworkers (25)  defined a  ConA-induced cloned T  cell population  in  Peyer's 
patches that causes surface IgM-bearing B cells to switch to surface IgA-bearing 
B cells (26). 
In summary, this study identifies two signals required for the activation of IgE 
synthesis in normal B cells. The initial signal is provided by clone 2H6. This first 
signal renders B cells responsive to the second signal provided by HIE T  cell- 
derived  IgE-BFs.  Since  B  cells  from  atopic  subjects  respond  to  IgE-BFs  by 
increased IgE synthesis, these B cells appear to have been activated in vivo by a 
first signal similar to that delivered by clone 2H6. 
Summary 
Two human alloreactive T  cell clones were established from a one-way mixed 
lymphocyte culture involving two nonatopic donors, and were assessed for their 
capacity to induce IgE synthesis by B cells obtained from the original stimulator. 
The two alloreactive T  cell clones studied induced IgG but not IgE synthesis in 
normal B cells. However, one of the two clones, clone 2H6, induced IgE synthesis 
in the presence of supernatants from T  cell lines derived from patients with the 
hyper-IgE syndrome (HIE), and enriched for T  cells bearing receptors for IgE. 
These supernatants by themselves caused no IgE synthesis in nonatopic B cells. 
The potentiating factors in these supernatants were shown to bind to IgE. Time 
sequence experiments indicated that interaction of the B cells with the alloreac- 
tive clone 2H6  renders them responsive to  the action of the  IgE-potentiating 
factors. 
These results indicate that induction of IgE synthesis in normal B cells involves 
at  least two sequential T  cell derived signals.  Furthermore, T  cell clones are 
heterogenous in their capacity to provide these signals. 
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